PTPRC is an immunotherapeutic predictor and serum biomarker in lung adenocarcinoma correlated with immune cell infiltration
Abstract Lung adenocarcinoma (LUAD) is the most common subtype of lung cancer, with the poor overall prognosis. PTPRC is an essential protein on the surface of cells of the immunological systems However, the role of PTPRC in LUAD has not been clarified. UALCAN, HPA and TCGA database were used to inv...
Saved in:
| Main Authors: | Yongwang Hou, Zhichao Yang, Zhicong Yang, Bin Zhang, Jiangmin Liu, Dandan Xu, Baoli Xiang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-15565-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characterization of the immune cell infiltration patterns in lung adenocarcinoma to facilitate immunotherapy
by: Haili Li, et al.
Published: (2025-02-01) -
FLT3LG modulates the infiltration of immune cells and enhances the efficacy of anti-PD-1 therapy in lung adenocarcinoma
by: Fengyu Zhao, et al.
Published: (2025-05-01) -
High matrix metalloproteinase-2 expression predicts poor prognosis of colon adenocarcinoma and is associated with PD-L1 expression and lymphocyte infiltration
by: Yiyi Xiao, et al.
Published: (2025-06-01) -
GNG7 as a tumor-suppressor gene in lung adenocarcinoma: implications for prognosis and immune-based therapies
by: Kexin Luo, et al.
Published: (2025-05-01) -
DCUN1D5 is a prognostic biomarker and correlated immune infiltrates and glycolysis in lung adenocarcinoma
by: Song Zhao, et al.
Published: (2025-01-01)